Briefing.com

Upgrades/Downgrades

Updated: 07-Oct-26 16:30 ET

Upgrades
Company Ticker Brokerage Firm Ratings Change Price Target
Allstate ALL HSBC Securities Hold » Buy $266
XPO, Inc. XPO Citigroup Neutral » Buy $224
Old Dominion ODFL Wolfe Research Underperform » Peer Perform
nLIGHT LASR Northcoast Neutral » Buy $75
Nexa Resources NEXA Morgan Stanley Equal-Weight » Overweight $14.20
NetApp NTAP Evercore ISI In-line » Outperform $300
Moelis MC UBS Sell » Neutral $59
Marvell MRVL TD Cowen Hold » Buy $350
Kroger KR BNP Paribas Exane Neutral » Outperform $72
Humana HUM Cantor Fitzgerald Neutral » Overweight $460
Flutter Entertainment FLUT Citigroup Neutral » Buy $91
Corteva CTVA KeyBanc Capital Markets Sector Weight » Overweight $17
Afya AFYA JP Morgan Neutral » Overweight $19
Downgrades
Company Ticker Brokerage Firm Ratings Change Price Target
Mohawk MHK RBC Capital Mkts Sector Perform » Underperform $112
UWM Holdings UWMC Keefe Bruyette Outperform » Mkt Perform $1.50
PJT Partners PJT Keefe Bruyette Outperform » Mkt Perform $159
Owens Corning OC RBC Capital Mkts Outperform » Sector Perform $127
Eni S.p.A. E BNP Paribas Exane Outperform » Neutral $56.30
Caribou Biosciences CRBU RBC Capital Mkts Outperform » Sector Perform $1
Caribou Biosciences CRBU Leerink Partners Outperform » Market Perform $1
Builders FirstSource BLDR RBC Capital Mkts Outperform » Sector Perform $62
AppFolio APPF UBS Buy » Neutral $220
AmBev ABEV BofA Securities Neutral » Underperform $3.30
Owens Corning OC Vertical Research Hold » Sell $106
Coverage Initiated
Company Ticker Brokerage Firm Ratings Change Price Target
AptarGroup ATR Deutsche Bank Buy $150
Vylor VYLR KeyBanc Capital Markets Sector Weight $78
Zimmer Biomet ZBH Barclays Equal Weight $100
TransMedics Group TMDX Barclays Overweight $120
Tandem Diabetes Care TNDM Barclays Equal Weight $18
Stryker SYK Barclays Overweight $375
Solstice Advance Materials SOLS Seaport Research Partners Buy $80
Senseonics SENS Barclays Equal Weight $10
Savara SVRA JP Morgan Overweight $12
SailPoint SAIL Oppenheimer Outperform $30
PROCEPT BioRobotics PRCT Barclays Overweight $30
MiniMed MMED Barclays Equal Weight $22
Medtronic MDT Barclays Equal Weight $95
M&T Bank MTB Raymond James Outperform $250
LivaNova LIVN Barclays Overweight $105
Intuitive Surgical ISRG Barclays Overweight $485
Insulet PODD Barclays Equal Weight $150
Inspire Medical Systems INSP Barclays Underweight $65
Humacyte HUMA Barclays Equal Weight $0.50
Honeywell Aerospace HONA Goldman Neutral $190
GE HealthCare GEHC Barclays Overweight $85
Edwards Lifesciences EW Barclays Overweight $110
Eagle Bancorp EGBN Hovde Group Outperform $37
Dexcom DXCM Barclays Overweight $115
Cooper COO Barclays Equal Weight $60
Brown & Brown BRO Oppenheimer Outperform $73
Boston Scientific BSX Barclays Equal Weight $48
Beta Bionics BBNX Barclays Overweight $30
Baxter BAX Barclays Underweight $20
Bausch + Lomb BLCO Barclays Overweight $24
AxoGen AXGN Barclays Overweight $55
Anteris Technologies Global Corp. AVR Barclays Equal Weight $10
Atour Lifestyle Hldgs. Ltd. ATAT HSBC Securities Buy $39.70
Ambiq Micro AMBQ Jefferies Buy $90
Alcon ALC Barclays Equal Weight $70
Abbott Labs ABT Barclays Overweight $120
Stevanato Group S.p.A. STVN Deutsche Bank Hold
Fossil FOSL Lake Street Buy $10
Arthur J. Gallagher AJG Oppenheimer Perform
Coverage Resumed
Company Ticker Brokerage Firm Ratings Change Price Target
T. Rowe Price TROW UBS Neutral $107
Franklin Templeton BEN UBS Buy $40
Invesco IVZ UBS Buy $41
Citizens Financial Group CFG Raymond James Strong Buy $77
(a) Brokerage firm initiating coverage participated in underwriting the recent IPO.
(b) Brokerage firm resumes coverage.
(c) Brokerage firm participated in the secondary offering.
* This list of reiterations/target changes is not comprehensive.

Copyright © Briefing.com. All rights reserved.